Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL.
Oncotarget
; 5(16): 6647-53, 2014 Aug 30.
Article
in En
| MEDLINE
| ID: mdl-25138051
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bone Neoplasms
/
RANK Ligand
/
Osteoprotegerin
/
Antibodies, Monoclonal, Humanized
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Oncotarget
Year:
2014
Type:
Article
Affiliation country:
Germany